MSIAN GENOMICS RES CENTRE BHD
KLSE (MYR): MGRC (0155)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.33
Today's Change
0.00 (0.00%)
Day's Change
0.00 - 0.00
Trading Volume
0
Financial
Market Cap
Market Cap
45 Million
NOSH
137 Million
Latest Quarter
Latest Quarter
30-Jun-2024 [#2]
Announcement Date
28-Aug-2024
Next Quarter
30-Sep-2024
Est. Ann. Date
28-Nov-2024
Est. Ann. Due Date
29-Nov-2024
QoQ | YoY
5.33% | 87.92%
T4Q Result
Revenue | NP to SH
7,578.000 | -10,256.000
RPS | P/RPS
5.52 Cent | 5.98
EPS | P/E | EY
-7.47 Cent | -4.41 | -22.65%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.14 | 2.36
QoQ | YoY
48.6% | 28.17%
NP Margin | ROE
-156.39% | -53.39%
F.Y. | Ann. Date
30-Jun-2024 | 28-Aug-2024
Latest Audited Result
Latest Audited Result
31-Dec-2023
Announcement Date
29-Mar-2024
Next Audited Result
31-Dec-2024
Est. Ann. Date
29-Mar-2025
Est. Ann. Due Date
29-Jun-2025
Annual (Unaudited)
Revenue | NP to SH
12,865.000 | -21,762.000
RPS | P/RPS
9.38 Cent | 3.52
EPS | P/E | EY
-14.56 Cent | -2.08 | -48.06%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.16 | 2.06
YoY
null%
NP Margin | ROE
-184.12% | -99.13%
F.Y. | Ann. Date
31-Dec-2023 | 28-Feb-2024
Annualized Result
Revenue | NP to SH
6,154.000 | -5,482.000
RPS | P/RPS
4.49 Cent | 7.36
EPS | P/E | EY
-4.00 Cent | -8.26 | -12.11%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
2.66% | 61.52%
NP Margin | ROE
-94.48% | -28.54%
F.Y. | Ann. Date
30-Jun-2024 | 28-Aug-2024
Business Process
| Trailing 4 Quarters | Trailing 8 Quarters | |||
|---|---|---|---|---|
| Available Quarters | 4 Quarters | 8 Quarters | ||
| Continuous Quarters Of Revenue Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Total Positive Profit Years | 0 / 4 | 0.00% | 1 / 8 | 12.50% |
| Continuous Quarters Of Positive Profit | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Profit Growth | 2 / 4 | 50.00% | 2 / 8 | 25.00% |
| Continuous Quarters Of Adjusted EPS Growth | 2 / 4 | 50.00% | 2 / 8 | 25.00% |
| Total Dividend Years | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Dividend | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Dividend Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Adjusted Dps Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Average ROE | -11.63% | -11.92% | ||
| Average Net Profit Margin | -147.94% | -202.53% | ||
| Last 5 Financial Years | Last 10 Financial Years | |||
|---|---|---|---|---|
| Available Years | 5 Years | 10 Years | ||
| Continuous Quarters Of Revenue Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
| Total Positive Profit Years | 1 / 5 | 20.00% | 4 / 10 | 40.00% |
| Continuous Quarters Of Positive Profit | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
| Continuous Quarters Of Profit Growth | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
| Continuous Quarters Of Adjusted EPS Growth | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
| Total Dividend Years | 0 / 5 | 0.00% | 1 / 10 | 10.00% |
| Continuous Quarters Of Dividend | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
| Continuous Quarters Of Dividend Growth | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
| Continuous Quarters Of Adjusted Dps Growth | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
| Average ROE | -31.57% | -2.68% | ||
| Average Net Profit Margin | -115.17% | 121.37% | ||
Key Result
| T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
|---|---|---|---|---|---|
| Revenue | 7,578 | 6,154 | 12,865 | 12,651 | 10,274 |
| NP to SH | -10,256 | -5,482 | -21,762 | -2,203 | -6,618 |
| Dividend | 0 | 0 | 0 | 2,277 | 0 |
| Adjusted EPS | -7.47 | -4.00 | -14.56 | -1.48 | -4.56 |
| Adjusted DPS | 0.00 | 0.00 | 0.00 | 1.66 | 0.00 |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
Growth
| LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
|---|---|---|---|---|---|
| Revenue | -26.55% | -41.54% | -63.21% | -31.22% | -34.61% |
| NP to Owner | 5.33% | 87.92% | 80.76% | 48.01% | 56.54% |
| Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Adjusted EPS | 5.83% | 87.93% | 80.74% | 48.10% | 56.60% |
| Adjusted DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
| T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | -41.10% | -26.24% | -40.10% | -52.16% | -40.10% | -51.36% | 0.00% | 25.22% | 1.69% |
| NP to Owner | 52.87% | -54.97% | -365.44% | 74.81% | 17.17% | -148.79% | 0.00% | -228.83% | -887.61% |
| Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Adjusted EPS | 48.70% | -63.70% | -406.13% | 72.53% | 12.34% | -171.02% | 0.00% | -219.08% | -886.52% |
| Adjusted DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
Discussions
3 people like this. Showing 50 of 1,465 comments
Kenanga Research starts coverage on MGRC, target price RM1.07
https://www.theedgemarkets.com/article/kenanga-research-starts-coverage-mgrc-target-price-rm107
2022-10-31 11:09
slow slow panjat , minggu lepas hijau , minggu ni hijau , minggu depan hijau , tiap tiap minggu hijau !
2022-11-07 13:43
This counter can out of sudden dropped 0.30 in a day ,happened before and Director said not sure what causes UMA. scary
2022-12-15 16:44
Azri actually just one of director , Mgrc helm by Sasha who is ceo of mgrc
2022-12-19 19:31
No need to be bad mood, you may continue to promote. we all can have a free speech and opinion in i3.
2023-01-05 14:30
Hopefully with the exit of Bintai, this counter can move up, and seems like someone is collecting at 0.74
2023-02-22 12:20
A lot of investors don't trust Azri aka the management because of his age. I am also from the younger generation and believe that the old investors should stop adopting the jaded and traditional mentality that youngsters cannot lead a company in the right direction. A short-term stagflation is upon us so this is a great opportunity for the company to seek the next trend in the healthcare/genomics space
2023-05-05 10:26
Let put our fingers crossed
As highlighted by public bank security
On 28/4 first resistance at 65 Cts followed by 72.5
2023-05-13 14:16
QR is out. Probably need to wait a few more quarters for its new business to be profitable
2023-05-23 14:10
I simply don't understand the price can hold at 50c....
It shld be 20c range
2023-05-23 15:35
Even SCIB want to vote him out, maybe MGRC should consider too ... He is still too young to handle this. Very good example - Bintai and he end up resign.
2023-06-26 14:15
hello peter sie, gambling away what is left of your dad's Ting Pek Khiing leftover cash
2023-07-26 20:26
Not sure what this new shareholder will bring to the tables, and how she can help to growth this company.
In fact, MGRC should not remove the previous director Mr Ku from the Board. He is the only one with actual management and biz skills. Mr. Ku Chong Hong is a well accomplished financial guru and began his career in auditing with several audit firms before joining Grant Thornton Malaysia as an Audit Senior Manager in 2017 .Throughout his career as an auditor for more than 8 years, he had gained vast exposure in audit and assurance, and business advisory related fields through his portfolios of various local and international companies.
He is also just appointed MD of SCIB. Look at all the positive developments he has displayed there. The share growth chart is amazing! People trust his ability and capabilities. Will drop MGRC and continue to long Bintai and SCIB...
2023-07-31 08:48
Super young Executive Chairman appointing his young gf to the board. Experienced management and directors leaving 1 by 1. Now you know why people don’t trust this greenhorn hamster. Thankfully sold all my shares here. Better follow Dato'Ku in SCIB/BKCB.
2023-08-22 07:31
Is the bull coming.mgrc 50 cents.Let see in next few days.
24/10/23 2.05pm
2023-10-24 14:06
Haha mafia sudah kena tangkap
Kikiki…
KUALA LUMPUR: The Securities Commission (SC) has charged two individuals in the Kuala Lumpur Sessions Court with 11 offences of money laundering involving over RM119 million.
The two individuals are Ang Jen Chuen (Dexter Ang), former director of Pixelvest Sdn Bhd, and Syaiful Riezal Ahmad, former chief executive officer of Infinity Trustee Bhd, the SC said in a statement today.
They were charged with receiving proceeds of unlawful activity under section 4(1)(b) of the Anti-Money Laundering, Anti-Terrorism Financing and Proceeds of Unlawful Activities 2001.
Dexter Ang and Syaiful Riezal faced eight and three charges respectively.
The alleged money laundering offences took place between Dec 1, 2020 and Jan 9, 2023 in Kuala Lumpur and Selangor.
The individuals claimed trial to their respective charges.
Sessions Court judge Tuan Azrul Darus granted bail at RM8.01 million with two sureties to Dexter Ang and RM100,000 with one surety to Syaiful Riezal.
They were also ordered to surrender their passports to the court and to report to the SC on a monthly basis until the completion of the trial.
If convicted, these individuals shall be liable to imprisonment for up to 15 years and shall also be liable to a fine of not less than five times the sum or value of the proceeds of the unlawful activities at the time the offence was committed or RM5 million, whichever is higher.
2024-01-10 21:27
Post a Comment
Featured Posts
Latest Videos
Apps
Top Articles
1
2
Good Articles to Share
3
4
Koon Yew Yin's Blog
Why all plantation companies will continue to report more profit - Koon Yew Yin
5
AmInvest Research Reports
6
7
save malaysia!
8
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Kennedy72
Can masuk ka. Risk reward ratio bagus
2022-08-31 17:14